Administered By

• Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

• Agios Pharmaceuticals, Inc. 

Contributors

• Rizzieri, David Alan Principal Investigator

Start/End

• July 1, 2019 - October 31, 2019